U.S. cardiology groups have worked together to propose the creation of a new American Board of Cardiovascular Medicine for certifying cardiologists. Now, after many months of waiting, a final decision is expected by the end of February. 

IHF cardiologists can come from a variety of backgrounds, but they all share the same goal: to ensure complex heart failure patients receive the best care possible. 

Many PAD patients do not even know they have the disease until it is too late, leading to unnecessary amputations and increasing the risk of other adverse patient outcomes. Awareness is especially limited among Black and Hispanic adults, experts warn, creating an added sense of urgency when looking to accelerate patient education efforts.

Frank J. Hildner, MD, is remembered by colleagues for his significant contributions to the field of interventional cardiology as well as his positivity, warmth and generosity. 

"This research should be a call to health systems, policymakers and other stakeholders to make it easier for patients—especially the most vulnerable patients—to access PAD-specific care," one cardiologist explained. 

SCAI President James Hermiller, MD, recently outlined the key achievements for 2024, including creation of the first interventional cardiology match program, successful advocacy and efforts to increase women in the field.

Back in 2019, the FDA issued a warning about the use of paclitaxel-coated devices when treating peripheral artery disease. The agency took back that warning in 2023, but it appears to have made a significant impact on patient care. 

The pressure changes associated with contrast injections are minimal, researchers noted, especially once you move away from the tip of the catheter.